Skip to content

Author

Shouta Saiki

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

LP.8.1-directed recombinant protein COVID-19 vaccine S-268025, formulated with squalene-based adjuvant A-910823, elicits robust immunogenicity and neutralizing breadth in mice.

SARS-CoV-2 continues to evolve by repeatedly undergoing antigenic mutations and evolving into different lineages, evading host immunity. Currently, viruses derived from the JN.1 lineages such as XFG and NB.1.8.1 strains have continued to spread globally, and the BA.3.2.2 strain has also been detected as a new lineage t...

Shouta Saiki, Miho Kuroiwa, Kumi Hashimoto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.